ANY SOLID TUMOR
Clinical trials for ANY SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new ANY SOLID TUMOR trials appear
Sign up with your email to follow new studies for ANY SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets hard-to-treat cancers with specific gene changes
Disease control OngoingThis early-phase study tests an oral drug called LY3410738 in people with advanced solid tumors (like bile duct cancer, bone cancer, or brain tumors) that have certain IDH gene mutations. The main goals are to find the safest dose and see if the drug can shrink tumors or slow the…
Matched conditions: ANY SOLID TUMOR
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Targeted pill shrinks tumors in people with RET-driven cancers
Disease control OngoingThis study tested an oral drug called selpercatinib in 857 people with advanced solid tumors that have a specific RET gene change. The goal was to see if the drug is safe and can shrink tumors. While it may control the cancer, it is not a cure, and ongoing treatment is needed.
Matched conditions: ANY SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 14, 2026 12:03 UTC